Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07052123

Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2 (estimated)
Sponsor
Centre Hospitalier de Saint-Denis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study tests a new non-invasive device called DARE to monitor blood pressure in patients in intensive care. It compares the device's readings to standard invasive methods and also looks at how well it measures other vital signs like temperature, oxygen levels, and heart rhythm. The goal is to improve patient safety and comfort while helping doctors detect problems earlier.

Conditions

Interventions

TypeNameDescription
DEVICEMultiSense® Non-Invasive Hemodynamic Monitoring DeviceThe MultiSense® device is a wireless, non-invasive monitoring system designed to continuously measure blood pressure, microcirculation, central body temperature, and detect arrhythmias in ICU patients. It aims to reduce risks associated with invasive monitoring, improve patient comfort and mobility, and decrease alarm fatigue through intelligent alert algorithms.

Timeline

Start date
2025-03-24
Primary completion
2028-03-24
Completion
2028-03-24
First posted
2025-07-04
Last updated
2025-07-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07052123. Inclusion in this directory is not an endorsement.